Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-21

Clinical Trial Update: Dorsomedial rTMS For Depression In Borderline Personality Disorder [NA]

View source ↗

Summary

Clinical trial investigating dorsomedial rTMS as a treatment for depression in people with Borderline Personality Disorder; currently status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Borderline Personality Disorder, Major Depression | NA | Status: UNKNOWN